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Abstract
Background—Quantitative methods for comparing intranasal drug delivery efficiencies pre- and
postoperatively have not been fully utilized. The objective of this study is to use computational
fluid dynamics techniques to evaluate aqueous nasal spray penetration efficiencies before and after
surgical correction of intranasal anatomic deformities.
Methods—Ten three-dimensional models of the nasal cavities were created from pre- and
postoperative computed tomography scans in five subjects. Spray simulations were conducted
using a particle size distribution ranging from 10–110μm, a spray speed of 3m/s, plume angle of
68°, and with steady state, resting inspiratory airflow present. Two different nozzle positions were
compared. Statistical analysis was conducted using Student T-test for matched pairs.
Results—On the obstructed side, posterior particle deposition after surgery increased by 118%
and was statistically significant (p-value=0.036), while anterior particle deposition decreased by
13% and was also statistically significant (p-value=0.020). The fraction of particles that by-passed
the airways either pre- or post-operatively was less than 5%. Posterior particle deposition
differences between obstructed and contralateral sides of the airways were 113% and 30% for pre-
and post-surgery, respectively. Results showed that nozzle positions can influence spray delivery.
Conclusions—Simulations predicted that surgical correction of nasal anatomic deformities can
improve spray penetration to areas where medications can have greater effect. Particle deposition
patterns between both sides of the airways are more evenly distributed after surgery. These
findings suggest that correcting anatomic deformities may improve intranasal medication delivery.
For enhanced particle penetration, patients with nasal deformities may explore different nozzle
positions.
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Topical administrations of intranasal medication are usually given by nasal drops, aqueous
spray pumps, and nebulizers. A combination of drug, device, and patient factors can
contribute to the efficacy of intranasal drugs. These include drug formulation characteristics,
delivery device design, delivery technique, site of deposition, nasal anatomy, and underlying
sinonasal medical conditions.1,2 Nasal anatomy is particularly significant since it is
characterized by variations across individuals. For subjects with nasal anatomic deformities
associated with nasal airway obstruction (NAO), deposition efficacy of aqueous spray
pumps have not been well described.
NAO is a common health condition known to affect all age groups and can negatively
impact mood, energy, recreation, sleep and overall quality of life.3 The prevalence of an
anatomic deformity such as deviated nasal septum in healthy adults is approximately 19.5–
26%.4 Allergic rhinitis and chronic rhinosinusitis, two conditions frequently treated with
topical intranasal medications, are common conditions estimated to affect 10–25% of the
general population.5,6 Therefore, it is very likely that many patients have co-existing
anatomic deformities and allergic/inflammatory conditions contributing to nasal obstruction.
However, there is sparse or no information in the literature about the effects of a septal
deviation or other anatomic deformities on delivery of topical medication to the areas of the
nasal cavity where it will have its greatest effect nor any reports of whether surgical
correction of such underlying anatomic deformity improve the efficacy of topical
medication.
With the availability of powerful bioengineering computer-aided design software,
anatomically-accurate, three dimensional (3D) computational models can be generated from
patient-specific digital data such as computed tomography (CT) scan images. Computational
fluid dynamics (CFD) techniques can be used to simulate the flow of air, heat transfer, air
humidification, and particulate transport through the 3D reconstructed nasal geometry.4,6–14
In a previous pilot study,7 we compared drug delivery penetration past the nasal valve of a
septal deviated patient using simulated aqueous spray pumps or nebulizers. However, the
study was limited to a pre-operative nasal geometry. A study by Moghadas, et al. 12
investigated micro- and nano-particle transport and deposition in pre- and post-operative
nasal passage models of a 25 years of male subject who underwent septoplasty. However,
this study was limited to one individual. The objective of the present study was to use CFD
techniques to evaluate aqueous nasal spray penetration efficiencies before and after surgical
correction of intranasal anatomic deformities in five patients.
METHODS
Subjects
Two males and three females between 27 and 53 years were enrolled from the patients who
presented to the Medical College of Wisconsin (MCW) Otolaryngology clinic for treatment.
The inclusion criteria were: 1) 15 years old or older, 2) clinical diagnosis of non-reversible,
surgically treatable cause for nasal obstruction (deviated septum, turbinate hypertrophy
resistant to medical treatment, or lateral nasal wall collapse), 3) elect nasal surgery, and 4)
give written informed consent. Exclusion criteria include chronic sinusitis, nasal polyposis,
and other forms of sinonasal disease. The research described here was approved by the
Institutional Review Board at MCW. Diagnosis of NAO and surgical treatment decisions
were made by the surgeon (JSR) based on clinical presentation and the standard of medical
care; all the patients were otherwise healthy.
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In order to eliminate any potential effects of nasal cycling on our CFD simulations as well as
avoiding sampling selection bias, the first five subjects with no obvious signs of congestion
and decongestion of the nasal mucosa in both pre- and post-operative CT scans were
selected in this study. The scans for all five subjects were done in 0.5mm slice increments,
with number of slices ranging from 191–216 (Pre) and 142–208 (Post), and pixel sizes of
0.303–0.313 mm. To allow for adequate healing time, postoperative CT scans were
performed between 5 and 8 months after surgery.
Pre-operative diagnoses revealed varying degree of moderate to severe septal deviation on
all five subjects, as well as additional nasal deformities shown in Table 1. All patients
underwent septoplasty and supplementary surgery consistent with their diagnoses. These
procedures are designed to improve airflow at the region of the nasal valve and beyond.
Post-surgical care was performed in the usual manner following nasal surgery with an
uneventful post-operative course.
Nasal Model Reconstruction
Pre- and post-operative CT scans were imported into a medical imaging software package,
Mimics™ 13.1 (Materialise, Inc., Plymouth, MI), and 3D reconstructions of each subject’s
nasal airways, excluding the paranasal sinuses, were created. The reconstructed nasal
models were exported from Mimics™ in STL (stereolithography) file format into the CAD
and mesh generating software package ICEM-CFD™ 12.1 (ANSYS, Canonsburg, PA).
Planar nostril and outlet surfaces were constructed, and regions for tracking particle
deposition were designated as follows: the anterior region, ranging from the nostrils up to
the nasal valve area, the middle region, consisting of the turbinates and adjacent nasal
septum, and the nasopharynx, defined as posterior to the turbinates and septum (Fig. 1A).
Airflow simulation
In order to solve the equations that govern fluid flow, computational meshes of each
subject’s pre- and post-surgery airways were created in ICEM-CFD™ using approximately 4
million graded tetrahedral elements, based on an in-house mesh density study indicating that
about 4 million elements provides mesh independent numerical results. Three layers of
prism elements were created at the nasal airway walls to accurately account for near-wall
particle trajectories. CFD simulations were carried out in two uncoupled phases, airflow and
particle transport.
Steady-state, laminar inspiratory airflow was simulated using the CFD software package
Fluent™ 12.1.4 (ANSYS, Inc., Canonsburg, PA) under pressure-driven conditions. The
boundary conditions specified in Fluent to determine the airflow field were identical to those
previously used:4,7 Briefly, these boundary conditions were: 1) a “wall” condition assuming
that the walls were stationary with zero air velocity at the air-wall interface; 2) a “pressure-
inlet” condition at the nostrils with gauge pressure set to zero; 3) a “pressure-outlet”
condition at the outlet with gauge pressure set to a pressure drop derived for each patient
that generated a pre-determined steady-state resting flow rate. This flow rate was calculated
to be twice the minute volume (amount of air inhaled in 1 min, defined as tidal volume times
respiratory rate) estimated from body weight using gender-specific power law curves
derived by Garcia, et al. 15
Spray specification and particle trajectories
The position of the simulated spray nozzle set to be 0.5cm into the nasal vestibule from the
nostril surface on each side for every patient, and was the largest distance of those reported
by Kimbell, et al. 8 that adequately fit into the nasal vestibule of all the patients. Simulated
sprays were initially directed laterally or to the side, away from the septum and toward the
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outer portion of the eye as recommended by Benninger, et al. 17 However, the angle from
the nostril center to the outer eye aimed the spray directly onto the lateral vestibule wall in
all patients and so was modified slightly to point toward the center of the eye rather than the
outer corner. In addition, to investigate whether the presence of a septal deviation may
require patients to alter the angle of nozzle insertion and angulation of spray pumps from the
slightly modified recommended technique (Position A),17 an alternative spray nozzle
position (Position B) was tested for Subject 5, such that spray was directed by rotating the
recommended nozzle position 42° inferiorly (Fig. 1B).
Simulated sprays consisted of aerosol particle sizes ranging from 10 to 110μm in
aerodynamic diameter, with a spray plume angle of 68° designed to resemble the Pfeiffer
spray pump PF-80 used by Cheng, et al. 18 The average velocity range of most
commercially available sprays is 1 to 14.7m/s,8,19 and the discharge velocity of flunisolide
(though unknown) was estimated to be 370cm/s (3.7m/s)20 so a simulated spray velocity of
3m/s was used here. Particle trajectories were calculated using the Discrete Phase Model in
Fluent™. Particles that exited the nasal airways at the outlet via the nasopharynx were
categorized as “Escaped.” For particles that deposited in the nasal cavity, the region where
each particle deposited was recorded. The “solid cone” injection type was specified in
Fluent™ to simulate particle streams that emanated from the spray release position at
randomly dispersed angles throughout the spray cone region. To characterize particle size
distribution in a polydisperse form, a Rosin Rammler Particle Size Distribution21 set to
range in aerodynamic diameter from 10 to 110μm with mean diameter of 66 μm and spread
distribution parameter of 2.89 was utilized.18 A total of 1100 particle streams were released
from each nostril.
Statistical Analysis
Statistical analysis was conducted on CFD simulated data to test the null hypothesis that
deviated nasal septum does not impact sprayed aerosol distribution on the obstructed side.
Student’s t-test for matched pairs was used to test this null hypothesis. Pre- and post-surgery
comparisons were done on anterior and posterior region deposition values and on the
number of particles that by-passed the entire nasal cavity (Escaped). Posterior deposition
was calculated as the sum of aerosolized particles that deposited in the middle and
nasopharynx regions.
RESULTS
Statistical tests of the null hypothesis comparing pre- and post-surgery deposition patterns in
the anterior, posterior, and escaped regions are presented in Table 2. Simulations predicted
that the presence of septal deviation significantly affected both anterior (p=0.01999) and
posterior deposition (p=0.03591), and that there was no significant difference in the number
of sprayed particles that escaped (p=0.05989) the nasal cavity on the obstructed side. CFD
results on the obstructed side showed that anterior deposition decreased by 13% after
surgery, while posterior deposition increased by 118% (Fig 2A). Sprayed aerosol deposition
on the contralateral (unobstructed) side indicated more particle penetration into the middle
and nasopharynx regions, and less anterior deposition before surgery than after (Fig. 2B). A
comparison of posterior particle distribution differences between obstructed and
contralateral sides of the airways were 113% and 30% for pre- and post-surgery,
respectively (Fig. 2C).
Comparisons between the two different interpretations of the recommended intranasal spray
technique17 (Positions A & B) for Subject 5 are displayed in Figure 3. In the pre-operative
nasal model (Fig. 3A); particle deposition patterns for the two spray positions were not
vastly different, although simulation results showed that ‘Position B’ had a slight lower
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anterior deposition, and more particles escaped the nasal cavity. Whereas in the post-
operative nasal geometry (Fig. 3B), simulation predicted that ‘Position B’ had superior
deposition efficiency; particle deposition in the anterior region of the nose dropped by 68%,
while aerosol penetration into the middle and nasopharynx regions improved by 1944% and
215%, respectively.
DISCUSSION
The results of this study, comparing aqueous nasal spray penetration efficiencies before and
after surgical correction of intranasal anatomic deformities in five NAO patients, indicate
that aerosolized particle penetration improved significantly post-surgery on the anatomically
obstructed side. At the same time, did not significantly impact the number of particles that
bypassed the nasal cavity at the nasopharynx. Simulation data suggests that altering the
angle of spray nozzle insertion may enhance aerosol particle deposition efficiency in the
nasal cavity after septoplasty. CFD analysis by Wang, et al. 13 showed that particle release
positions influence local deposition patterns in a healthy subject, further supporting the
results of this study indicating that subjects may be well-advised to explore various spray
nozzle positions. In agreement with other studies,6,7,9,11 our simulations predicted that
smaller particles had superior nasal valve penetration pre- and post-operatively in all the
subjects, while larger particle sizes deposited directly into the anterior region (Fig. 4).
These results pose significant clinical implications, since the scenario of a patient with an
underlying mucosal inflammatory process – e.g. rhinitis, sinusitis – coupled with an
anatomical nasal deformity is a common one. The surgical correction of an underlying
anatomic deformity may greatly increase the efficacy of medical management. The common
management strategy of required pre-surgical nasal steroid trials for treatment of nasal
obstruction symptoms may be flawed in its logic.22 The presence of a moderate to severe
septal deviation or other anatomic deformity, as was the case in all our study subjects,
hinders nasal spray drug delivery, implying that the effectiveness of nasal spray usage pre-
surgically is essentially suboptimal. Therefore, while no definitive conclusions can be made
based on this study alone, in a patient with co-existing anatomic and inflammatory
conditions one may consider proceeding with surgical planning to address the anatomic
components at the time of initiating a nasal spray medication as the drug delivery will be
greatly enhanced if the affected nasal passage side is normalized in its anatomical
configuration, as well as creating a more even particle distribution between both sides of the
nasal airways.
In this study, airflow was simulated under laminar conditions. Although nasal airflow may
become turbulent at flow rates occurring during sniffing or exercise, there is evidence that
laminar conditions dominate nasal air flows at resting breathing rates.10,14 For the purposes
of focusing this study on a comparison of pre- and post-surgery spray deposition, time-
dependent effects of the breathing cycle were not considered. Steady-state simulation results
were assumed to be representative of particle deposition over time and capable of
discriminating pre- and post-surgery differences when conducted in a consistent manner as
was done here. Finally, while we did demonstrate a statistically significant improvement in
penetration to the more posterior portions of the nose, the study design did not allow
correlation with actual patient symptoms or response to drug therapy so no definitive clinical
or pharmacological conclusions can be made.
In conclusion, the present CFD comparative study of aqueous nasal spray penetration
efficiencies before and after nasal surgery determined that surgical correction of nasal
anatomic deformities can improve spray penetration to areas where medications can have
greater effect. Further study will be necessary to find spray nozzle position(s) that can
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maximize aerosolized particle penetration, a standardized recommended nozzle position
may be useful as a starting point for patient education on usage of nasal sprays, but given the
uniqueness of individual patient anatomy, our results suggest that alterations in spray nozzle
position may be needed to optimize intranasal drug delivery.
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(A)Sagittal view of the obstructed side of the nasal passage showing regions used for
tracking particle deposition (green, anterior; purple, middle; blue, nasopharynx).
(B) Nozzle positions based on the recommended technique17 showing superior (Position A)
spray axis and release point (blue), and inferior (Position B) spray axis and release point
(red) in Subject 5.
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Pre- and post-operative regional deposition patterns on the obstructed side of the nasal
passage.
(A) Obstructed side (means + standard deviation).
(B) Unobstructed side (means + standard deviation).
(C) Deposition differences between obstructed and contralateral sides (Posterior deposition=
middle + nasopharynx).
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Pre- and post-operative spatial deposition patterns.
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Table 1
Patients’ diagnoses and surgical intervention
Subject Diagnoses Predominate side of
obstruction
Performed procedure
1 Deviated nasal septum
External nasal deformity
Left Septorhinoplasty
2 Deviated nasal septum
External nasal deformity
Inferior turbinate compensatory hypertrophy
Right Septorhinoplasty
Left inferior turbinectomy
3 Deviated nasal septu
External nasal deformit
Inferior turbinate compensatory hypertrophy
Right Septorhinoplasty
Left inferior turbinectomy
4 Bilateral vestibular stenosis
Deviated nasal septum
Bilateral inferior turbinate hypertrophy
Right Bilateral vestibular stenosis repaired with butterfly onlay
graft
Septoplasty
Bilateral inferior turbinate turbinectomy
5 Deviated nasal septum
Inferior turbinate compensatory hypertrophy
Left middle turbinate concha bullosa
Right Septoplasty
Left inferior turbinectomy
Left middle turbinate concha bullosa resection
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Table 2
Test of hypothesis that deviated nasal septum does not impact sprayed aerosol distribution on the deviated side
for n=5. Pre and post-surgery regional particle deposition patterns are presented as means ± standard
deviation. Statistical comparisons were carried out using Student’s t-test for matched pairs. P-value<0.05
indicate statistical significance (all cases).
Region Pre Post P-value
Anterior 999.8±36.1 869.8±111.1 0.01999
Posterior 87.4±43.0 190.4±113.9 0.03591
Escaped 12.8±24.9 39.6±33.0 0.05989
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